Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aviscera Bioscience is a leading supplier of high-sensitivity ELISA kits, monoclonal antibodies, recombinant proteins and biotinylated proteins for life science research. Their products support biomarker discovery and quantification in areas such as cardiovascular disease, metabolic syndrome/diabetes complications, cancer biology/oncology biomarkers, osteoporosis/bone metabolism disorders as well as neuroscience and inflammation. The company is recognized for its precision high-sensitivity human biomarker ELISA kits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aviscera Bioscience.